Menu
GeneBe

15-80153057-G-A

Variant summary

Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong

The NM_000137.4(FAH):c.3G>A(p.Met1?) variant causes a start lost change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,134 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

FAH
NM_000137.4 start_lost

Scores

4
8
3

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 8.01
Variant links:
Genes affected
FAH (HGNC:3579): (fumarylacetoacetate hydrolase) Predicted to enable fumarylacetoacetase activity. Predicted to be involved in L-phenylalanine catabolic process; homogentisate catabolic process; and tyrosine catabolic process. Predicted to act upstream of or within arginine catabolic process. Located in extracellular exosome. Implicated in tyrosinemia type I. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 20 ACMG points.

PVS1
Start lost variant, no new inframe start found.
PS1
Another start lost variant in NM_000137.4 (FAH) was described as [Likely_pathogenic] in ClinVar as 371005
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 15-80153057-G-A is Pathogenic according to our data. Variant chr15-80153057-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 950962.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FAHNM_000137.4 linkuse as main transcriptc.3G>A p.Met1? start_lost 1/14 ENST00000561421.6
FAHNM_001374377.1 linkuse as main transcriptc.3G>A p.Met1? start_lost 2/15
FAHNM_001374380.1 linkuse as main transcriptc.3G>A p.Met1? start_lost 2/15

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FAHENST00000561421.6 linkuse as main transcriptc.3G>A p.Met1? start_lost 1/141 NM_000137.4 P1P16930-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD3 exomes
AF:
0.00000798
AC:
2
AN:
250716
Hom.:
0
AF XY:
0.00000737
AC XY:
1
AN XY:
135622
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000881
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461134
Hom.:
0
Cov.:
32
AF XY:
0.00000138
AC XY:
1
AN XY:
726926
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33
Bravo
AF:
0.00000378
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Tyrosinemia type I Pathogenic:3
Pathogenic, no assertion criteria providedclinical testingNatera, Inc.Jul 27, 2017- -
Pathogenic, criteria provided, single submitterclinical testingInvitaeDec 30, 2023This sequence change affects the initiator methionine of the FAH mRNA. The next in-frame methionine is located at codon 71. This variant is present in population databases (rs766882348, gnomAD 0.003%). Disruption of the initiator codon has been observed in individual(s) with tyrosinemia type I (PMID: 21764616, 22802474, 24016420). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 950962). For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 02, 2023Variant summary: FAH c.3G>A (p.Met1Ile) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon. Other variants that disrupt the initiator codon have been reported in association with Tyrosinaemia 1 in HGMD. Three of three in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 250716 control chromosomes. The next downstream in-frame initiation codon is at codon 71 and other pathogenic variants have been reported upstream of this potential in-frame start codon. c.3G>A has been reported in the literature as a homozygous genotype in individuals affected with Tyrosinemia Type 1 (Ibarra-Gonzalez_2019). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.56
D
BayesDel_noAF
Pathogenic
0.41
Cadd
Uncertain
26
Dann
Uncertain
1.0
DEOGEN2
Benign
0.075
T;D;D;D
Eigen
Uncertain
0.54
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.90
D;.;.;D
M_CAP
Pathogenic
0.91
D
MetaRNN
Pathogenic
0.98
D;D;D;D
MetaSVM
Uncertain
0.48
D
MutationTaster
Benign
1.0
D;D;D
PROVEAN
Uncertain
-2.9
D;D;D;D
Sift
Uncertain
0.012
D;D;D;D
Sift4G
Benign
0.090
T;T;T;T
Polyphen
0.93
.;P;P;P
Vest4
0.94, 0.83, 0.92
MutPred
0.97
Gain of catalytic residue at M1 (P = 0.0374);Gain of catalytic residue at M1 (P = 0.0374);Gain of catalytic residue at M1 (P = 0.0374);Gain of catalytic residue at M1 (P = 0.0374);
MVP
0.88
ClinPred
0.97
D
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.78
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs766882348; hg19: chr15-80445399; API